Hydrops Fetalis Pediatric Research and Clinical Trials

Thalassemia, specifically alpha thalassemia, is one cause and hemolytic disease is another. The pediatric hematologists at Dana-Farber/Boston Children's Hospital are experts in the genetic evaluation of families at risk for both immune and non-immune hydrops due to severe fetal anemia.

For more information about current research, visit www.danafarberbostonchildrens.org.

We are proud to serve a broad and diverse patient population that often comes to us for answers they can't find anywhere else. This top ranking is a credit and a tribute to our extraordinary and deeply committed clinicians, researchers and so many others who dedicate every day to improving and advancing the health and well-being of all children.

Hydrops Fetalis Pediatric Research and Clinical Trials

Sandra L. Fenwick, CEO

About Boston Children's

I want to:

Public Relations